The role of facemask spirometry in motor neuron disease

Thorax

Volumn 68, Issue 4, 2013, Pages 385-386

  Banerjee, Sandip Kamakhya ^a   Davies, Michael ^a   Sharples, Linda ^b   Smith, Ian ^a  

^a PAPWORTH HOSPITAL   (United Kingdom)

^b MRC BIOSTATISTICS UNIT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BULBAR PARALYSIS; DUCHENNE MUSCULAR DYSTROPHY; FACE MASK; FORCED VITAL CAPACITY; HUMAN; LETTER; LUNG FUNCTION TEST; MAXIMAL INSPIRATORY MOUTH PRESSURE; MICROCOMPUTER; MOTOR NEURON DISEASE; MUSCLE STRENGTH; PRIORITY JOURNAL; QUALITY OF LIFE; SNIFF NASAL INSPIRATORY PRESSURE; SPIROMETRY; SURVIVAL RATE;

EID: 84875224880     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2012-201804     Document Type: Letter

References (5)

1. NICE clinical guideline 105. Mot Neurone Disease: The Use Of Non-Invasive Ventilation In The Management Of Motor Neurone Disease. 2010. http:www.nice.org.uk/guidance/CG105
2. Chaudri MB, Liu C, Kinnear WJ, et al. Sniff nasal inspiratory pressure as a marker of respiratory function in motor neurone disease. Eur Respir J 2000;15:539-42. (Pubitemid 30158192)
3. Wohlgemuth M, Van der Kooi E, Hendriks J, et al. Face mask spirometry and respiratory pressures in normal subjects. Eur Respir J 2003;22:1001-6. (Pubitemid 37540656)
4. Bourke S, Tomlinson M, Williams T, et al. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis. A randomised controlled trial. Lancet Neurol 2006;5:140-7. (Pubitemid 43109171)
5. Raphael JC, Chevret S, Chastang C, et al. Randomised trial of preventive nasal ventilation in Duchenne muscular dystrophy. Lancet 1994;343: 1600-4. (Pubitemid 24194807)